In summary, increasing ketone body availability and hepatic PPARα activity through a ketogenic diet or ketone ester supplementation in mice with lung cancer did not increase survival, nor did it improve the maintenance of body weight and muscle mass. The gene discussed is PPARA; the disease is lung cancer.